SPY308.08+2.53 0.83%
DIA257.85+2.58 1.01%
IXIC9,608.38+56.33 0.59%

ZIOPHARM Oncology Q1 EPS $(0.090) Beats $(0.630) Estimate

ZIOPHARM Oncology (NASDAQ:ZIOP) reported quarterly losses of $(0.090) per share which beat the analyst consensus estimate of $(0.630) by 85.71 percent. This is a 12.5 percent decrease over losses of $(0.080) per share

Benzinga · 05/07/2020 20:27

ZIOPHARM Oncology (NASDAQ:ZIOP) reported quarterly losses of $(0.090) per share which beat the analyst consensus estimate of $(0.630) by 85.71 percent. This is a 12.5 percent decrease over losses of $(0.080) per share from the same period last year.